ERBB2 and neoplasm: We evaluated the cytotoxic action of two antitumor agents, the high-molecular-weight HER2-specific targeted toxin, DARPin-LoPE, and the low-molecular-weight chemotherapy drug, doxorubicin, against the tumor spheroids, SKOV-kat, and compared it with the effect on monolayer culture.